331 related articles for article (PubMed ID: 34409799)
1. Expression of Ki-67, Cyclin D1, P53, and P16 in patients with oral leukoplakia and leukoplakia cancerization with spicy diet in Chengdu.
Wan ZX; Zheng ZJ; Huang MC; Chen Y; Yao LH
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Aug; 39(4):434-440. PubMed ID: 34409799
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias.
Nasser W; Flechtenmacher C; Holzinger D; Hofele C; Bosch FX
J Oral Pathol Med; 2011 Sep; 40(8):629-35. PubMed ID: 21435003
[TBL] [Abstract][Full Text] [Related]
3. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
4. Nuclear Epidermal Growth Factor Receptor Overexpression as a Survival Predictor in Oral Squamous Cell Carcinoma.
Tarle M; Raguž M; Muller D; Lukšić I
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982894
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus genotypes and p16 expression in oral leukoplakia and squamous cell carcinoma.
Yang LQ; Xiao X; Li CX; Wu WY; Shen XM; Zhou ZT; Fan Y; Shi LJ
Int J Clin Exp Pathol; 2019; 12(3):1022-1028. PubMed ID: 31933914
[TBL] [Abstract][Full Text] [Related]
6. [The p16 methylation in oral leukoplakia and oral squamous cell carcinoma].
Liu HW; Hu BQ; Cao CF
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):94-7. PubMed ID: 15842853
[TBL] [Abstract][Full Text] [Related]
7. CDK4, CDK6, cyclin D1 and Notch1 immunocytochemical expression of oral brush liquid-based cytology for the diagnosis of oral leukoplakia and oral cancer.
Kujan O; Huang G; Ravindran A; Vijayan M; Farah CS
J Oral Pathol Med; 2019 Aug; 48(7):566-573. PubMed ID: 31172614
[TBL] [Abstract][Full Text] [Related]
8. DEC1: a potential biomarker of malignant transformation in oral leukoplakia.
Mao T; Xiong H; Hu X; Hu Y; Wang C; Yang L; Huang D; Xia K; Su T
Braz Oral Res; 2020; 34():e052. PubMed ID: 32578762
[TBL] [Abstract][Full Text] [Related]
9. Influence of PD-1/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma.
Xu SB; Wang MY; Shi XZ; Wang Q; Yu M; Zhang W; Xu XH; Liu LK
Oral Dis; 2023 Nov; 29(8):3268-3277. PubMed ID: 35921211
[TBL] [Abstract][Full Text] [Related]
10. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
[TBL] [Abstract][Full Text] [Related]
11. [Expression of Ki-67 and P53 protein in oral squamous cell carcinoma and its clinical significance].
He W; Xiao Y; Chen WM
Shanghai Kou Qiang Yi Xue; 2015 Apr; 24(2):228-31. PubMed ID: 25938156
[TBL] [Abstract][Full Text] [Related]
12. Expression of FAP in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
Li R; Zhang R; Shi X; Jiao X; Li Y; Zhao Y; Liu T; Zhang C
Int Dent J; 2024 Jun; 74(3):581-588. PubMed ID: 38278714
[TBL] [Abstract][Full Text] [Related]
13. Copy Number Alterations Predict Development of OSCC from Oral Leukoplakia.
Cai X; Zhang J; Li L; Liu L; Tang M; Zhou X; Peng C; Li X; Chen X; Xu M; Zhang H; Wang J; Huang Y; Li T
J Dent Res; 2024 Feb; 103(2):138-146. PubMed ID: 38217281
[TBL] [Abstract][Full Text] [Related]
14. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
Cao J; Jin JQ; Deng DJ; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders.
Abrahao AC; Bonelli BV; Nunes FD; Dias EP; Cabral MG
Braz Oral Res; 2011; 25(1):34-41. PubMed ID: 21359449
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
[TBL] [Abstract][Full Text] [Related]
17. Expression of p16, p53 and Ki-67 proteins in the progression of epithelial dysplasia of the oral cavity.
Angiero F; Berenzi A; Benetti A; Rossi E; Del Sordo R; Sidoni A; Stefani M; Dessy E
Anticancer Res; 2008; 28(5A):2535-9. PubMed ID: 19035275
[TBL] [Abstract][Full Text] [Related]
18. Compositional and functional changes in the salivary microbiota related to oral leukoplakia and oral squamous cell carcinoma: a case control study.
Lan Q; Zhang C; Hua H; Hu X
BMC Oral Health; 2023 Dec; 23(1):1021. PubMed ID: 38115005
[TBL] [Abstract][Full Text] [Related]
19. Expressions of Interleukin-27 in Oral Lichen Planus, Oral Leukoplakia, and Oral Squamous Cell Carcinoma.
Wang QM; Huang XY; Guan WQ
Inflammation; 2022 Jun; 45(3):1023-1038. PubMed ID: 35064378
[TBL] [Abstract][Full Text] [Related]
20. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.
Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P
Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]